Skip to main content
. Author manuscript; available in PMC: 2022 Jan 14.
Published in final edited form as: Nature. 2021 Jul 14;595(7868):600–605. doi: 10.1038/s41586-021-03721-x

Extended Data Table 1.

GRK mutations and their impact on kinase activity towards Rho* or a soluble substrate.

αN Helix Rho* soluble substrate Ref
ΔN19 GRK1 ---- --- 29
ΔN2–14 GRK5 ---- NC 7
D2A GRK1 NC NC 62
D3A GRK2 - ND§ 5,34
D3N GRK2 - ND 34
D3K GRK2 ---- NC 34
S5E GRK1 +|| --
S5A GRK1 -- ND 45
L6A GRK1 --- + 35
L4A GRK2 --- NC 34
L4A GRK2 -- + 5
L4K GRK2 ---- ND 34
L3Q GRK5 -- ND 7
L3Q/K113R GRK5 --- NC 7
L3A GRK6 - NC 6
E7A GRK1 --- + 35
E5A GRK2 - NC 34
E4A GRK6 - - 6
T8A GRK1 - ND 45
T8E GRK1 -- ND 45
V9A GRK1 ---- + 35
V7E GRK2 -- + 5
I6A GRK6 --- NC 6
V10A GRK1 ---- + 35
V7A GRK6 --- NC 6
L7A/8A GRK2 ---- ND 34
I6A/V7A GRK6 ---- NC 6
I6E/V7E GRK6 ---- NC 6
A11E GRK1 - - 35
N12A GRK1 ---- --- 35
D10A GRK2 --- NC 5,34
D10A GRK2 - - 5
D10R GRK2 -- - 5
N9A GRK6 ---- -- 6
T10P GRK5 -- NC 7
F15A GRK1 ---- ---- 35
Y13A GRK2 ---- - 5
L12A GRK6 ---- - 6
I16A GRK1 -- -- 35
L13A GRK6 -- -- 6
M15A GRK2 NC + 5
A18E GRK1 -- -- 35
A16V GRK2 NC - 5
M17A GRK2 - - 5
E18A GRK2 + ND 5
AST region Rho* soluble substrate Ref
P473A GRK2 NC ND 63
P473E GRK2 - - 63
R474A GRK2 NC ND 5
R470A GRK5 - ND 64
G475I GRK2 - - 5
E476K GRK2 NC ND 63
V476A GRK1 ---- --- 29
V477D GRK2 --- - 63
N478A GRK2 NC ND 5
A479S GRK2 NC ND 5
A480S GRK2 NC ND 5
N480A GRK1 + ND 29
D481A GRK2 NC ND 63
A482I GRK2 - ND 5
Q482A GRK1 + ND 29
F483A GRK2 NC ND 63
D483A GRK1 - ND 29
D484A GRK2 NC ND 63
V484A GRK1 ---- ---- 29
I485A GRK2 - - 63
F487A GRK1 - ND 29
F488D GRK2 NC ND 63
S488E/T489E GRK1 NC -
S488D/T489D GRK1 - -
S5E/S488E/T489E GRK1 + NC
E490K GRK2 NC ND 63
G495A GRK2 NC ND 63
L499D GRK2 NC ND 63
Small lobe Rho* soluble substrate Ref
F190A GRK1 --- ---- 29
F190Y GRK1 NC ND 29
F190H GRK1 + ND 29
R191A GRK1 ---- ---- 29
R191K GRK1 ---- ---- 29
R195A GRK2 ---- ND 29
R190A GRK6 ---- ND 29
V192A GRK1 NC ND 29
R195A GRK1 - ND 29
Q205A GRK1 + ND 29
G210E GRK1 -- ND 29
L212A GRK1 --- --- 29
L212M GRK1 + ND 29
N268A GRK1 NC ND 29
Large lobe Rho* soluble substrate Ref
H280A GRK2 NC ND 63
Y274A GRK1 ---- ---- 29
Y274F GRK1 + ND 29
Y281A GRK2 - - 63
H275A GRK1 + ND 29
S284A GRK2 NC ND 63
Q285A GRK2 NC ND 63
Q285K GRK2 NC ND 63
K395A GRK2 NC ND 63
K397A GRK2 NC ND 63
RH domain Rho* soluble substrate Ref
5A GRK1 ---- ND
D164A GRK1 - ND 45
L166K GRK1 - ND 45
D164A/L166K GRK1 - ND 45
L33N GRK2 NC NC 2
E36A GRK2 NC NC 65,2
V42E GRK2 -- ND 65
Y46A GRK2 - ND 65
R68A GRK5 + ND 66
P61A/Q69A GRK5 = ND 66
L66A/H38A GRK5 --- ND 66
L66A/P73A GRK5 --- ND 66
L66A/E514A GRK5 --- ND 66
L66A/P37A GRK5 --- ND 66
L66A/R69A GRK6 -- ND 66
L66A/Q172A GRK6 ---- ND 66
F166A/H38A GRK5 --- ND 66
F166A/E514A GRK5 --- ND 66
F166A/P61A GRK5 --- - 66
F166A/L66A GRK5 --- - 66
Y166A/L66A GRK6 ---- ND 66
F166A/Q172A GRK5 --- ND 66
Y166A/Q172A GRK6 ---- ND 66
Y166A/L176A GRK6 --- ND 66
F166A/W173A GRK5 --- - 66
Q172A/I176A GRK5 --- - 66
Q172A/W173A GRK6 ---- ND 66
E96A GRK2 NC ND 65
R516A GRK2 NC ND 65
E520A GRK2 -- ND 65
E532A GRK2 NC NC 2
L536N GRK2 NC NC 2
L547N GRK2 NC NC 2
P638D GRK2 -- ND 65
V92A GRK5 ND NC 31
V92L GRK5 ND NC 31
V92M GRK5 ND NC 31
K454A GRK5 ND NC 31
R455A GRK5 ND NC 31
K454A/R455A GRK5 ND NC 31
I39E/I165E GRK6 NC ND 67
I165E/F527D GRK6 NC ND 67

----, >100-fold reduction; ----, 20–100 fold reduction; ---, 10–20 fold reduction; --, 5–10 fold reduction; -, 3–5 fold reduction.

NC, no change.

§

ND, not determined.

||

+, 1–3 fold increase.

Mutation is characterized in the current paper.